NCT00251186View on ClinicalTrials.gov

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

PHASE2TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Colorectal Cancer
Interventions
DRUG

Capecitabine and Cetuximab

Trial Locations (1)

08901

The Cancer Institute of New Jersey, New Brunswick

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER